With the U.S. Food & Drug Administration (FDA) this week finalizing a rule-change that allows brick-and-mortar pharmacies to dispense mifepristone online, if permitted under state law, a lawsuit challenging the regulatory review and safety of “abortion pills” bound for trial in the Texas Panhandle assumes added significance.
Alliance Defending Freedom filed a 113-page lawsuit on Nov. 18 in the U.S. District Court for the Northern District of Texas in Amarillo on behalf of the Alliance for Hippocratic Medicine and an array of other organizations and individuals, arguing the FDA did not properly approve mifepristone for terminating pregnancies.
The suit seeks a preliminary junction suspending the prescription of “mifepristone and misoprostol as FDA-approved chemical abortion drugs” while the legal challenge works its way to trial, perhaps as soon as this spring….
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta